These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8409765)

  • 21. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assembly of very low density lipoproteins in rat liver: a study of nascent particles recovered from the rough endoplasmic reticulum.
    Swift LL
    J Lipid Res; 1995 Mar; 36(3):395-406. PubMed ID: 7775852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.
    Le NA; Innis-Whitehouse W; Li X; Bakker-Arkema R; Black D; Brown WV
    Metabolism; 2000 Feb; 49(2):167-77. PubMed ID: 10690940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations of VLDL composition during alimentary lipemia.
    Björkegren J; Hamsten A; Milne RW; Karpe F
    J Lipid Res; 1997 Feb; 38(2):301-14. PubMed ID: 9162750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein B sequence requirements for hepatic very low density lipoprotein assembly. Evidence that hydrophobic sequences within apolipoprotein B48 mediate lipid recruitment.
    McLeod RS; Wang Y; Wang S; Rusiñol A; Links P; Yao Z
    J Biol Chem; 1996 Aug; 271(31):18445-55. PubMed ID: 8702489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of lipoprotein lipase to apolipoprotein B-containing lipoproteins.
    Carrero P; Gómez-Coronado D; Olivecrona G; Lasunción MA
    Biochim Biophys Acta; 1996 Jan; 1299(2):198-206. PubMed ID: 8555265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein and lipid distribution between vesicles and HDL-like particles formed during lipolysis of human very low density lipoproteins by perfused rat heart.
    Tam SP; Breckenridge WC
    J Lipid Res; 1983 Oct; 24(10):1343-57. PubMed ID: 6644185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway.
    Sehayek E; Eisenberg S
    J Biol Chem; 1991 Sep; 266(27):18259-67. PubMed ID: 1917954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rat McA-RH7777 cells efficiently assemble rat apolipoprotein B-48 or larger fragments into VLDL but not human apolipoprotein B of any size.
    Xiao Q; Elovson J; Schumaker VN
    J Lipid Res; 2000 Jan; 41(1):116-25. PubMed ID: 10627509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterization of lipoproteins produced by human hepatoma-derived cell lines other than HepG2.
    Forte TM; McCall MR; Knowles BB; Shore VG
    J Lipid Res; 1989 Jun; 30(6):817-29. PubMed ID: 2551986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
    Dinkel RE; Barrett PH; Demant T; Parhofer KG
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Well-defined regions of apolipoprotein B-100 undergo conformational change during its intravascular metabolism.
    Wang X; Pease R; Bertinato J; Milne RW
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1301-8. PubMed ID: 10807746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and secretion of lipoproteins by human hepatocytes in culture.
    Bouma ME; Pessah M; Renaud G; Amit N; Catala D; Infante R
    In Vitro Cell Dev Biol; 1988 Feb; 24(2):85-90. PubMed ID: 3125144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions.
    Packard CJ; Demant T; Stewart JP; Bedford D; Caslake MJ; Schwertfeger G; Bedynek A; Shepherd J; Seidel D
    J Lipid Res; 2000 Feb; 41(2):305-18. PubMed ID: 10681415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential metabolism of human VLDL according to content of ApoE and ApoC-III.
    Tomiyasu K; Walsh BW; Ikewaki K; Judge H; Sacks FM
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1494-500. PubMed ID: 11557678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product.
    Alaupovic P; Wang CS; McConathy WJ; Weiser D; Downs D
    Arch Biochem Biophys; 1986 Jan; 244(1):226-37. PubMed ID: 3080947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects.
    Barrett PH; Baker N; Nestel PJ
    J Lipid Res; 1991 May; 32(5):743-62. PubMed ID: 2072038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
    Forster LF; Stewart G; Bedford D; Stewart JP; Rogers E; Shepherd J; Packard CJ; Caslake MJ
    Atherosclerosis; 2002 Sep; 164(1):129-45. PubMed ID: 12119202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.